Treats infections caused by susceptible strains of the designated organisms in the…. ANDA 61837, held by Watson Labs. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 61837 (Tetracycline Hydrochloride), held by Watson Labs, was first approved by FDA on Dec 24, 1974, with 20 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 24, 1974 | Original application | Approved | None posted |
| Tetracycline Hydrochloride250MG · capsule;oral | Tetracycline Hydrochloride | Rx |
| Tetracycline Hydrochloride500MG · capsule;oral | Tetracycline Hydrochloride | Rx |
| Mar 31, 2025 | Supplement 44Labeling · Standard review | Approved | None posted |
| Mar 14, 2025 | Supplement 39Labeling · Standard review | Approved | None posted |
| Mar 14, 2025 | Supplement 35Labeling · Standard review | Approved | None posted |
| May 20, 2002 | Supplement 24Manufacturing | Approved | None posted |
| Dec 21, 1999 | Supplement 23Manufacturing | Approved | None posted |
| Nov 10, 1999 | Supplement 22Manufacturing | Approved | None posted |
| Nov 10, 1999 | Supplement 21Manufacturing | Approved | None posted |
| Oct 1, 1999 | Supplement 20Manufacturing | Approved | None posted |
| Oct 1, 1999 | Supplement 19Manufacturing | Approved | None posted |
| May 20, 1999 | Supplement 18Manufacturing | Approved | None posted |
| Dec 1, 1998 | Supplement 17Manufacturing | Approved | None posted |
| Jul 30, 1998 | Supplement 16Manufacturing | Approved | None posted |
| Oct 10, 1997 | Supplement 15Manufacturing | Approved | None posted |
| May 8, 1996 | Supplement 14Manufacturing | Approved | None posted |
| Dec 23, 1994 | Supplement 13Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 12Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 11Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 9Manufacturing | Approved | None posted |
| Oct 16, 1991 | Supplement 8Labeling | Approved | None posted |
| Feb 14, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Dec 24, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters